Ion channels in genetic and acquired forms of epilepsy

Journal of Physiology

Volumn 591, Issue 4, 2013, Pages 753-764

  Lerche, Holger ^a   Shah, Mala ^b   Beck, Heinz ^c   Noebels, Jeff ^d   Johnston, Dan ^e   Vincent, Angela ^f  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY HOSPITAL BONN   (Germany)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e University of Texas at Austin   (United States)

^f UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CALCIUM CHANNEL; CALCIUM CHANNEL CAV3.2; CYCLIC NUCLEOTIDE GATED CHANNEL; ION CHANNEL; POTASSIUM CHANNEL; POTASSIUM CHANNEL KV7; POTASSIUM CHANNEL KV7.2; POTASSIUM CHANNEL KV7.3; SODIUM CHANNEL NAV1.1; UNCLASSIFIED DRUG;

AMPA3 GENE; BRAIN REGION; CACNA1A GENE; CACNAB4 GENE; EPILEPSY; FMR1 GENE; GENE; GENE EXPRESSION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; NERVE CELL EXCITABILITY; NONHUMAN; NONSENSE MUTATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SCN8A GENE; TEMPORAL LOBE EPILEPSY;

ANIMALS; ANTIBODIES; EPILEPSY; HUMANS; ION CHANNELS; MUTATION;

EID: 84873708403     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2012.240606     Document Type: Review

References (58)

1. Aponte Y, Lien CC, Reisinger E & Jonas P (2006). Hyperpolarization-activated cation channels in fast-spiking interneurons of rat hippocampus. J Physiol 574, 229-243.
2. Becker AJ, Pitsch J, Sochivko D, Opitz T, Staniek M, Chen CC et al (2008). Transcriptional upregulation of Cav3.2 mediates epileptogenesis in the pilocarpine model of epilepsy. J Neurosci 28, 13341-13353.
3. Bender RA, Soleymani SV, Brewster AL, Nguyen ST, Beck H, Mathern GW & Baram TZ (2003). Enhanced expression of a specific hyperpolarization-activated cyclic nucleotide-gated cation channel (HCN) in surviving dentate gyrus granule cells of human and experimental epileptic hippocampus. J Neurosci 23, 6826-6836.
4. Biel M, Wahl-Schott C, Michalakis S & Zong X (2009). Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 89, 847-885.
5. Bien CG, Urbach H, Schramm J, Soeder BM, Becker AJ, Voltz R et al (2007). Limbic encephalitis as a precipitating event in adult-onset temporal lobe epilepsy. Neurology 69, 1236-1244.
6. Brager DH, Akhavan AR & Johnston D (2012). Impaired dendritic expression and plasticity of h-channels in the fmr1-/y mouse model of fragile X syndrome. Cell Rep 1, 225-233.
7. Brewster A, Bender RA, Chen Y, Dube C, Eghbal-Ahmadi M & Baram TZ (2002). Developmental febrile seizures modulate hippocampal gene expression of hyperpolarization-activated channels in an isoform- and cell-specific manner. J Neurosci 22, 4591-4599.
8. Chen K, Aradi I, Thon N, Eghbal-Ahmadi M, Baram TZ & Soltesz I (2001). Persistently modified h-channels after complex febrile seizures convert the seizure-induced enhancement of inhibition to hyperexcitability. Nat Med 7, 331-337.
9. Dube CM, Brewster AL & Baram TZ (2009). Febrile seizures: mechanisms and relationship to epilepsy. Brain Dev 31, 366-371.
10. Dugladze T, Vida I, Tort AB, Gross A, Otahal J, Heinemann U et al (2007). Impaired hippocampal rhythmogenesis in a mouse model of mesial temporal lobe epilepsy. Proc Natl Acad Sci U S A 104, 17530-17535.
11. Dyhrfjeld-Johnsen J, Morgan RJ, Foldy C & Soltesz I (2008). Upregulated H-current in hyperexcitable CA1 dendrites after febrile seizures. Front Cell Neurosci 2, 2.
12. Engel JJ (1996). Introduction to temporal lobe epilepsy. Epilepsy Res 26, 141-150.
13. Ernst WL, Zhang Y, Yoo JW, Ernst SJ & Noebels JL (2009). Genetic enhancement of thalamocortical network activity by elevating α1g-mediated low-voltage-activated calcium current induces pure absence epilepsy. J Neurosci 29, 1615-1625.
14. Feldt S, Bonifazi P & Cossart R (2011). Dissecting functional connectivity of neuronal microcircuits: experimental and theoretical insights. Trends Neurosci 34, 225-236.
15. Frankel WN, Taylor L, Beyer B, Tempel BL & White HS (2001). Electroconvulsive thresholds of inbred mouse strains. Genomics 74, 306-312.
16. Glasscock E, Qian J, Yoo JW & Noebels JL (2007). Masking epilepsy by combining two epilepsy genes. Nat Neurosci 10, 1554-1558.
17. Glasscock E, Yoo JW, Chen TT, Klassen TL & Noebels JL (2010). Kv1.1 potassium channel deficiency reveals brain-driven cardiac dysfunction as a candidate mechanism for sudden unexplained death in epilepsy. J Neurosci 30, 5167-5175.
18. Goldman AM, Glasscock E, Yoo J, Chen TT, Klassen TL & Noebels JL (2009). Arrhythmia in heart and brain: KCNQ1 mutations link epilepsy and sudden unexplained death. Sci Transl Med 1, 2ra6.
19. Hawkins NA, Martin MS, Frankel WN, Kearney JA & Escayg A (2011). Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus. Neurobiol Dis 41, 655-660.
20. Heinzen EL, Depondt C, Cavalleri GL, Ruzzo EK, Walley NM, Need AC et al (2012). Exome sequencing followed by large-scale genotyping fails to identify single rare variants of large effect in idiopathic generalized epilepsy. Am J Hum Genet 91, 293-302.
21. Huang Z, Lujan R, Kadurin I, Uebele VN, Renger JJ, Dolphin AC & Shah MM (2011). Presynaptic HCN1 channels regulate Cav3.2 activity and neurotransmission at select cortical synapses. Nat Neurosci 14, 478-486.
22. Huang Z, Walker MC & Shah MM (2009). Loss of dendritic HCN1 subunits enhances cortical excitability and epileptogenesis. J Neurosci 29, 10979-10988.
23. Hughes EG, Peng X, Gleichman AJ, Lai M, Zhou L, Tsou R et al (2010). Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci 30, 5866-5875.
24. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR et al (2011). Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69, 892-900.
25. Jung S, Warner LN, Pitsch J, Becker AJ & Poolos NP (2011). Rapid loss of dendritic HCN channel expression in hippocampal pyramidal neurons following status epilepticus. J Neurosci 31, 14291-14295.
26. Kearney JA, Yang Y, Beyer B, Bergren SK, Claes L, Dejonghe P & Frankel WN (2006). Severe epilepsy resulting from genetic interaction between Scn2a and Kcnq2. Hum Mol Genet 15, 1043-1048.
27. Klassen T, Davis C, Goldman A, Burgess D, Chen T, Wheeler D et al (2011). Exome sequencing of ion channel genes reveals complex profiles confounding personal risk assessment in epilepsy. Cell 145, 1036-1048.
28. Lalic T, Pettingill P, Vincent A & Capogna M (2011). Human limbic encephalitis serum enhances hippocampal mossy fiber-CA3 pyramidal cell synaptic transmission. Epilepsia 52, 121-131.
29. Maljevic S & Lerche H. 2011. Epileptogenesis in idiopathic epilepsy. In: Shorvon S, Andermann F, Guerrini R (ed): The Causes of Epilepsy, Chapter 2, Cambridge University Press.
30. McClelland S, Flynn C, Dube C, Richichi C, Zha Q, Ghestem A et al (2011). Neuron-restrictive silencer factor-mediated hyperpolarization-activated cyclic nucleotide gated channelopathy in experimental temporal lobe epilepsy. Ann Neurol 70, 454-464.
31. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M et al (2005). Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65, 1730-1736.
32. Matt L, Michalakis S, Hofmann F, Hammelmann V, Ludwig A, Biel M & Kleppisch T (2011). HCN2 channels in local inhibitory interneurons constrain LTP in the hippocampal direct perforant path. Cell Mol Life Sci 68, 125-137.
33. Musumeci SA, Bosco P, Calabrese G, Bakker C, De Sarro GB, Elia M, Ferri R & Oostra BA (2000). Audiogenic seizures susceptibility in transgenic mice with fragile X syndrome. Epilepsia 41, 19-23.
34. Noebels J (2011). A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia 52, 39-46.
35. Ogiwara I, Miyamoto H, Morita N, Atapour N, Mazaki E, Inoue I et al (2007). Nav1.1 localizes to axons of parvalbumin-positive inhibitory interneurons: a circuit basis for epileptic seizures in mice carrying an Scn1a gene mutation. J Neurosci 27, 5903-5914.
36. Palop JJ, Chin J, Roberson ED, Wang J, Thwin MT, Ly NB, Yoo JW, Ho1 KO, Yu1 GQ, Kreitzer A, Finkbeiner S, Noebels JL, Mucke L (2007). Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease. Neuron 55, 697-711.
37. Poolos NP, Migliore M & Johnston D (2002). Pharmacological upregulation of h-channels reduces the excitability of pyramidal neuron dendrites. Nat Neurosci 5, 767-774.
38. Quek AM, Britton JW, McKeon A, So E, Lennon VA, Shin C et al (2012). Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol (Epublish ahead of print).
39. Reid CA, Berkovic SF & Petrou S (2009) Mechanisms of human inherited epilepsies. Prog Neurobiol 87, 41-57.
40. Rogers SW, Andrews PI, Gahring LC, Whisenand T, Cauley K, Crain B et al (1994). Autoantibodies to glutamate receptor GluR3 in Rasmussen's encephalitis. Science 265, 648-651.
41. Santoro B, Lee JY, Englot DJ, Gildersleeve S, Piskorowski RA, Siegelbaum SA et al (2010). Increased seizure severity and seizure-related death in mice lacking HCN1 channels. Epilepsia 51, 1624-1627.
42. Shah MM, Anderson AE, Leung V, Lin X & Johnston D (2004). Seizure-induced plasticity of h channels in entorhinal cortical layer III pyramidal neurons. Neuron 44, 495-508.
43. Shah MM, Hammond RS & Hoffman DA (2010). Dendritic ion channel trafficking and plasticity. Trends Neurosci 33, 307-316.
44. V7 (M-) channels as targets for epilepsy treatment. Neuropharmacology (Epublish ahead of print).
45. Singh NA, Otto JF, Dahle EJ, Pappas C, Leslie JD, Vilaythong A et al (2008). Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization. J Physiol 586, 3405-3423.
46. Sisodiya SM & Mefford HC (2011). Genetic contribution to common epilepsies. Curr Opin Neurol 24, 140-145.
47. 2+ channel causes a long-lasting modification of neuronal firing mode after status epilepticus. J Neurosci 22, 3645-3655.
48. Veeramah KR, O'Brien JE, Meisler MH, Cheng X, Dib-Hajj SD, Waxman SG et al (2012). De novo pathogenic SCN8A mutation identified by whole-genome sequencing of a family quartet affected by infantile epileptic encephalopathy and SUDEP. Am J Hum Genet 90, 502-510.
49. Verret L, Mann EO, Hang GB, Barth AM, Cobos I, Ho K et al (2012). Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell 149, 708-721.
50. Vincent A, Bien CG, Irani SR & Waters P (2011a). Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10, 759-772.
51. Vincent A, Buckley C, Schott JM, Dewar BK, Detert N et al (2004). Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain 127, 701-712.
52. Vincent A, Irani SR & Lang B (2011b). Potentially pathogenic autoantibodies associated with epilepsy and encephalitis in children and adults. Epilepsia 52, 8-11.
53. Walker MC & Kullmann DM (1999). Febrile convulsions: a 'benign' condition Nat Med 5, 871-872.
54. Watson R, Jiang Y, Bermudez I, Houlihan L, Clover L & McKnight K et al (2004). Absence of antibodies to glutamate receptor type 3 (GluR3) in Rasmussen encephalitis. Neurology 63, 43-50.
55. Weber YG & Lerche H (2008). Genetic mechanisms in idiopathic epilepsies. Dev Med Child Neurol 50, 648-654.
56. Wierschke S, Lehmann TN, Dehnicke C, Horn P, Nitsch R & Deisz RA (2010). Hyperpolarization-activated cation currents in human epileptogenic neocortex. Epilepsia 51, 404-414.
57. Yu FH, Mantegazza M, Westenbroek RE, Robbins CA, Kalume F, Burton KA et al (2006). Reduced sodium current in GABAergic interneurons in a mouse model of severe myoclonic epilepsy in infancy. Nat Neurosci 9, 1142-1149.
58. Zhang Y, Mori M, Burgess DL & Noebels JL (2002). Mutations in high-voltage-activated calcium channel genes stimulate low-voltage-activated currents in mouse thalamic relay neurons. J Neurosci 22, 6362-6371.